Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Common Equity (2021 - 2025)

Tenon Medical has reported Common Equity over the past 5 years, most recently at $5.0 million for Q4 2025.

  • Quarterly results put Common Equity at $5.0 million for Q4 2025, down 15.59% from a year ago — trailing twelve months through Dec 2025 was $5.0 million (down 15.59% YoY), and the annual figure for FY2025 was $5.0 million, down 15.59%.
  • Common Equity for Q4 2025 was $5.0 million at Tenon Medical, up from $4.8 million in the prior quarter.
  • Over the last five years, Common Equity for TNON hit a ceiling of $15.1 million in Q2 2022 and a floor of -$22.7 million in Q1 2022.
  • Median Common Equity over the past 5 years was $3.1 million (2023), compared with a mean of $1.5 million.
  • Biggest five-year swings in Common Equity: crashed 682.38% in 2022 and later surged 706.85% in 2025.
  • Tenon Medical's Common Equity stood at -$20.6 million in 2021, then surged by 130.42% to $6.3 million in 2022, then tumbled by 87.56% to $778000.0 in 2023, then surged by 667.48% to $6.0 million in 2024, then dropped by 15.59% to $5.0 million in 2025.
  • The last three reported values for Common Equity were $5.0 million (Q4 2025), $4.8 million (Q3 2025), and $6.7 million (Q2 2025) per Business Quant data.